Adfinitas Health

AdfinitasHealth.com

Adfinitas Health (formerly MDICS) is the trusted partner of more than 50 healthcare systems, hospitals, and post-acute care centers in the Mid-Atlantic region. Founded in 2007, this physician-owned and managed company provides high-quality, cost-effective integrated medical services across the full continuum of care in hospitals and post-acute facilities. Its unique integrated staffing model, unwavering commitment to client satisfaction, and focus on improving patient outcomes, make possible real opportunities to transform care and drive value for its clients.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

SOPHIA GENETICS LAUNCHES NEW SOLUTION TO ADVANCE CHRONIC LYMPHOCYTIC LEUKEMIA CARE, IN COLLABORATION WITH IDIBAPS

biotech, biotechnology, cell, gene, tissue | June 10, 2022

news image

SOPHiA GENETICS (Nasdaq: SOPH), the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) of Barcelona, and the Spanish Diagnóstica Longwood today announced from the European Hematology Association Congress in Vienna that they have combined their expertise to develop a new Chronic Lymphocytic Leukemia (CLL) solution to advance CLL care. This collaboration will unify the wide variety of current guideline recommendations into one single application aiming to improve ...

Read More

INDUSTRIAL IMPACT

O2 INVESTS IN MODULAR DEVICES, INC.

O2 Investment Partners ( | January 24, 2022

news image

O2 Investment Partners announced that it has partnered with Modular Devices, Inc. and its President & CEO, Greg Mink, to support the Company’s continued growth. Terms of the deal were not disclosed. Founded in 1987, Modular Devices, Inc. is a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions throughout the United States. MDI’s medical imaging solutions offer various imaging modalities through short- and long-term leases t...

Read More

MEDICAL

INVEST ONTARIO SUPPORTS NEW BIOMANUFACTURING FACILITY IN HAMILTON

Invest Ontario | April 01, 2022

news image

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson's and diabetes. OmniaBio, a Canadian cell and gene therapy contract development and manufacturing organization (CDMO), will be the anchor tenant in a new biomanufacturing campus being built in Ha...

Read More

MEDTECH

ZS AND SEVEN BRIDGES COLLABORATE TO INNOVATE DRUG RESEARCH

ZS, Seven Bridges | May 07, 2021

news image

ZS and Seven Bridges disclosed a collaboration today that will merge ZS's experience in biomedical testing facilities and data science with Seven Bridges' technology platform, which enables multi-omics analytics through the translational and clinical continuum. The hybrid offers biopharmaceutical and biotechnology firms a one-stop-shop for multi-omics analysis innovation and scalability. ZS and Seven Bridges work together to help clients produce breakthrough science, promote drug develop...

Read More
news image

MEDICAL

SOPHIA GENETICS LAUNCHES NEW SOLUTION TO ADVANCE CHRONIC LYMPHOCYTIC LEUKEMIA CARE, IN COLLABORATION WITH IDIBAPS

biotech, biotechnology, cell, gene, tissue | June 10, 2022

SOPHiA GENETICS (Nasdaq: SOPH), the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) of Barcelona, and the Spanish Diagnóstica Longwood today announced from the European Hematology Association Congress in Vienna that they have combined their expertise to develop a new Chronic Lymphocytic Leukemia (CLL) solution to advance CLL care. This collaboration will unify the wide variety of current guideline recommendations into one single application aiming to improve ...

Read More
news image

INDUSTRIAL IMPACT

O2 INVESTS IN MODULAR DEVICES, INC.

O2 Investment Partners ( | January 24, 2022

O2 Investment Partners announced that it has partnered with Modular Devices, Inc. and its President & CEO, Greg Mink, to support the Company’s continued growth. Terms of the deal were not disclosed. Founded in 1987, Modular Devices, Inc. is a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions throughout the United States. MDI’s medical imaging solutions offer various imaging modalities through short- and long-term leases t...

Read More
news image

MEDICAL

INVEST ONTARIO SUPPORTS NEW BIOMANUFACTURING FACILITY IN HAMILTON

Invest Ontario | April 01, 2022

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancer, cardiovascular diseases, Parkinson's and diabetes. OmniaBio, a Canadian cell and gene therapy contract development and manufacturing organization (CDMO), will be the anchor tenant in a new biomanufacturing campus being built in Ha...

Read More
news image

MEDTECH

ZS AND SEVEN BRIDGES COLLABORATE TO INNOVATE DRUG RESEARCH

ZS, Seven Bridges | May 07, 2021

ZS and Seven Bridges disclosed a collaboration today that will merge ZS's experience in biomedical testing facilities and data science with Seven Bridges' technology platform, which enables multi-omics analytics through the translational and clinical continuum. The hybrid offers biopharmaceutical and biotechnology firms a one-stop-shop for multi-omics analysis innovation and scalability. ZS and Seven Bridges work together to help clients produce breakthrough science, promote drug develop...

Read More